M Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13
- Investments
-
189
- Portfolio
-
78
- Exits
-
35
M Ventures General Information
Company Description
Founded in 2009, M Ventures is a corporate venture capital investment arm of Merck headquartered in Amsterdam, Netherlands. The firm invests in biotechnology and technology sectors. The firm focuses on the areas of healthcare drug development, life science tools, electronics, and frontier technology & sustainability.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- Eduard van
- Beinumstraat 26
- 1077 CZ Amsterdam
- Netherlands
M Ventures Investments (189)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Actithera | 09-Jul-2025 | Early Stage VC | Biotechnology | Pre-Clinical Trials | ||
| ReproNovo | 20-May-2025 | Other Healthcare Services | Clinical Trials - Phase 2 | |||
| ChEmpower | 15-May-2025 | Other Commercial Products | Generating Revenue | |||
| Biolinq | 22-Apr-2025 | Monitoring Equipment | Clinical Trials - Phase 2 | |||
| MemryX | 27-Mar-2025 | Application Specific Semiconductors | Generating Revenue | |||
| TRIMTECH Therapeutics | 05-Mar-2025 | Drug Discovery | Startup | |||
| SeeQC | 23-Jan-2025 | Application Specific Semiconductors | Generating Revenue | |||
| NovoLINC | 21-Jan-2025 | Computers, Parts and Peripherals | Startup | |||
| Klarna | 20-Jan-2025 | Later Stage VC | Financial Software | Profitable | ||
| Pictor Labs | 16-Jan-2025 | Later Stage VC | Diagnostic Equipment | Generating Revenue |
M Ventures Exits (35)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Tignis | 07-Jan-2025 | Merger/Acquisition | |
| Scipio Bioscience | 18-Sep-2024 | ||
| Sentaur Biosciences | 02-Mar-2024 | ||
| Metabomed | 08-Feb-2024 | ||
| Calypso Biotech | 07-Jan-2024 | ||
| Macrophage Pharma | 05-Dec-2023 | ||
| Synaffix | 31-May-2023 | ||
| Immunorizon | 15-Feb-2023 | ||
| Vaximm | 03-Nov-2022 | Secondary Transaction - Private | |
| Aveni | 05-Sep-2022 | Bankruptcy: Liquidation |
M Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
M Ventures Co-Investors (452)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Foothill Ventures | 5 |
|
|
||
| Pfizer Ventures |
|
|
|||
| Sofinnova Partners |
|
|
|||
| EQT Life Sciences |
|
|
|||
| Insight Partners (New York) |
|
|
M Ventures FAQs
-
What is M Ventures?
Founded in 2009, M Ventures is a corporate venture capital investment arm of Merck headquartered in Amsterdam, Netherlands.
-
When was M Ventures founded?
M Ventures was founded in 2009.
-
Where is M Ventures headquartered?
M Ventures is headquartered in Amsterdam, Netherlands.
-
What is M Ventures's total asset value?
M Ventures has around in total assets under management.
-
How many investments has M Ventures made?
M Ventures has made 189 investments.
-
What has M Ventures invested in?
M Ventures has made numerous investments in companies like Actithera, ReproNovo, and ChEmpower within the Biotechnology, Healthcare Services, and Commercial Products industries.
-
What has M Ventures invested in recently?
M Ventures's latest investment was on 09-Jul-2025 in Actithera, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
